Related Experiment Video
Updated: Jan 22, 2026

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with structural heart disease: A
Rushil Shah1, Fabrizio Assis1, Navya Alugubelli2
1Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Insights
Cardiac sympathetic denervation (CSD) effectively reduces ventricular arrhythmias (VAs) in patients with structural heart disease (SHD). While complications occur, most are temporary, with major issues being infrequent, making CSD a viable adjunctive therapy.
Area of Science:
- Cardiology
- Cardiac Surgery
- Electrophysiology
Background:
- Cardiac sympathetic denervation (CSD) is a key treatment for refractory ventricular arrhythmias (VAs).
- Efficacy of CSD in structural heart disease (SHD) patients with VAs is inconsistently reported.
- This study addresses the variability in CSD outcomes for SHD patients.
Purpose of the Study:
- To systematically review arrhythmic outcomes after CSD in SHD patients.
- To evaluate procedural complications associated with CSD in this population.
- To clarify the role of CSD in managing refractory VAs in SHD.
Main Methods:
- Systematic review of studies on CSD in SHD patients.
- Searched PubMed and Google Scholar for relevant literature.
- Excluded patients with known channelopathies; analyzed demographic, surgical, and outcome data.
Main Results:
- Included 13 studies with 173 SHD patients (mean age 54.6 years; 70% male).
- Overall freedom from VAs ranged from 58% to 100%.
- Complications occurred in 28% of patients, with transient hypotension and pneumothorax being most common; no procedure-related deaths.
Conclusions:
- CSD effectively reduces VA events in SHD patients, independent of the specific heart condition.
- The overall complication rate is notable, but most are temporary and minor.
- CSD is a safe and effective adjunctive therapy for refractory VAs in SHD patients.
Background:
Cardiac sympathetic denervation (CSD) is an important adjunctive option for patients with refractory ventricular arrhythmias (VAs). Reports of efficacy of CSD in patients with structural heart disease (SHD) and refractory VA vary widely in literature.
Objective:
The purpose of this study was to conduct a systematic review of arrhythmic outcomes and complications in patients with SHD who underwent CSD due to recurrent VAs.
Methods:
Electronic databases (Google Scholar and PubMed) were searched to identify reports on CSD in SHD using appropriate medical subject terms. No sample size restriction was applied. All patients with known channelopathies were excluded. Baseline demographic and surgical data, arrhythmic outcomes, and procedural complications were evaluated.
Results:
A total of 13 studies and 173 patients were included. Of the 173 patients (121 [70%] male); pooled mean age 54.6 [95% confidence interval 52.6-56.7] years), 48 (28%) had ischemic cardiomyopathy, and 141 (82%) underwent bilateral CSD. Overall freedom from events ranged from 58% to 100%. Complications were reported in 49 patients(28%). Transient hypotension (9%), pneumothorax (5%), neuropathic pain (skin sensitivity) (4%), Horner syndrome (3%), sweating pattern changes (3%), and hemothorax (2%) were the most common complications. No procedure-related deaths were reported.
Conclusion:
CSD reduced the number of VA events in patients with SHD, and the benefit from the intervention seemed to be independent of the underlying SHD. Although overall rate of postprocedural complications was high, most of the complications were temporary. Major postprocedural complications after CSD were infrequent.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mechanism of Cardiac Arrhythmias
The Sympathetic Nervous System
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Physiology of the Heart: The Cardiac Cycle
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Anatomy of the Heart

